🇺🇸 FDA
Patent

US 10406167

Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance

granted A61KA61K31/555A61K47/546

Quick answer

US patent 10406167 (Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance) held by The Board of Regents of the University of Texas System expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/555, A61K47/546, A61K47/547, A61K47/60